UniProtKB/Swiss-Prot Q12906: Variant p.Asp50His

Interleukin enhancer-binding factor 3
Gene: ILF3
Feedback?

Variant information Variant position:

50 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Histidine (H) at position 50 (D50H, p.Asp50His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (D) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1064493 [ dbSNP | Ensembl ]

Sequence information Variant position:

50 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

894 The length of the canonical sequence.
Location on the sequence:

AVQNMVSHTERALKAVSDWI D EQEKGSSEQAESDNMDVPPE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         AVQNMVSHTERALKAVSDWIDEQEKGSSEQAESDNMDVPPE

Mouse                         AVQNMVSHTERALKAVSDWIDEQEKGNSELSEAENMDTPPD

Rat                           AVQNMVSHTERALKAVSDWIDEQEKGNSELSEAENMDTPPD

Xenopus tropicalis            AVQNMVSHTERALKAVSDWIDQQEKDCSGEQEQPEPEEPET

Zebrafish                     GVQNMVSHTERALKLVSDWLDDQEKGNAKVNALDT-----D

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 894	Interleukin enhancer-binding factor 3
Domain	5 – 378	DZF
Region	50 – 86	Disordered
Modified residue	62 – 62	Phosphoserine

Literature citations
The 90- and 110-kDa human NFAR proteins are translated from two differentially spliced mRNAs encoded on chromosome 19p13.
Saunders L.R.; Jurecic V.; Barber G.N.;
Genomics 71:256-259(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2); VARIANT HIS-50;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.